Employers are projecting a median 10% increase in healthcare costs for 2026, driven largely by high claims and specialty drug expenses, according to a recent survey.

Pfizer’s inclacumab did not beat a placebo in a Phase 3 test in sickle cell disease. The trial failure comes nearly a year after Pfizer voluntarily withdrew Oxbryta from the market after tests ...

Isaac Health, a startup specializing in cognitive care for Alzheimer’s dementia , raised $10.5 million in Series A funding to expand nationwide access to its platform. The company partners with ...

The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” ...

Response Pharmaceuticals takes a new approach to weight loss with an oral small molecule designed to inhibit a protein called iMTP to reduce uptake of fats and cholesterol. While this drug’s ...

You don’t have to practice in Florida for this law to matter. Patient interest in regenerative care is growing rapidly, and ...

A new initiative from the Digital Medicine Society aims to replace outdated mental health questionnaires with a set of shared digital measures that track things like patients’ sleep, activity ...

Medical coding startup Arintra raised $21 million in Series A funding to help hospitals and physician groups secure accurate, timely reimbursement. The company’s AI-powered platform automates ...